A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Clinical trial NCT07564596 · RECRUITING

Trial details

NCT number: NCT07564596
Sponsor: Climb Bio, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erthematosus

Start date: 2026-06-30
Primary completion: 2027-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.